A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novavax can ...
Novavax on Thursday deferred its target to become profitable by a year to 2028 as changes in U.S. vaccination policy have ...
Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts of the ...
The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain committed ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
This is a major update to a story that was first published earlier in September. It reflects what readers need to know after an important vaccine advisory panel met on Thursday and Friday. Getting a ...
The COVID-19 vaccine rollout in 2025 is shaping up to be significant different than in past years. The U.S. Food and Drug Administration has approved updated vaccines under new guidelines, but the U.S ...
Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM ESTCompany ParticipantsRuxandra Draghia-Akli - Executive VP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback